Crossmark

Frequency and functional translation of low muscle mass in overweight and obese patients with COPD

Published Online: 2021-03-25

Published Print: 2021-12

Authors

Machado, Felipe V. C. http://orcid.org/0000-0003-1910-7695
Spruit, Martijn A.

Groenen, Miriam T. J.

Houben-Wilke, Sarah

van Melick, Paula P.

Hernandes, Nidia A.

Schols, Annemie M. W. J.

Pitta, Fabio

Wouters, Emiel F. M.

Franssen, Frits M. E.
Funding

Funding for this research was provided by:

Lung Foundation Netherlands (3.4.10.015)

GlaxoSmithKline (SCO115406)
License Information

Text and Data Mining valid from 2021-03-25

Version of Record valid from 2021-03-25
More Information

Article History

Received: 13 November 2020

Accepted: 22 March 2021

First Online: 25 March 2021

Declarations

:

: The current analysis used data from the Chance Study which was approved by the Medical Ethical Committee of the Maastricht University Medical Centre + (METC 11-3-070). The present study was approved by the board of directors of CIRO (Horn, the Netherlands). All patients gave written informed consent and the study was carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current